← Product Code LXM · K060043 # KHAN KINETIC TREATMENT DEVICE (KKT-M1) (K060043) _Optima Health Solutions International, Inc. · LXM · Mar 23, 2006 · PM · SESE_ **Canonical URL:** https://fda.innolitics.com/device/K060043 ## Device Facts - **Applicant:** Optima Health Solutions International, Inc. - **Product Code:** LXM - **Decision Date:** Mar 23, 2006 - **Decision:** SESE - **Submission Type:** Traditional - **Device Class:** Class U - **Review Panel:** PM - **Attributes:** Therapeutic ## Intended Use The KKT device is to be used in the aid of management of chronic pain due to non-congenital defects. The device can be used as part of a series of steps in the total care of the patient. The device is to be used for the treatment of vertebral motor units which appear to be fixated. The procedure can involve xray analysis that quantifies the lateral and rotational misalignments between the vertebrae. The treatment is then administered using the KKT device to deliver precise impulses at a required vector configuration. ## Device Story KKT-M1 is a chiropractic treatment system for vertebral motor unit fixation; manages chronic pain from non-congenital defects. Input: clinician-determined vector configuration based on X-ray analysis of lateral/rotational vertebral misalignments. Operation: device delivers precise, adjustable, and repeatable mechanical impulses to the spine; replaces manual manipulation to reduce injury risk from unregulated force. Used in clinical settings by trained practitioners. Output: controlled mechanical force/vibration. Benefit: improved positioning accuracy and repeatability compared to manual adjustments; reduced potential for unintended injury. ## Clinical Evidence Bench testing only. Verification of electrical safety (CSA 601.1, UL 2601/60601-1, IEC 60601.1) and EMC (IEC 60601.1-2, EN55022, EN61000) performed. Formal design verification procedure conducted. No clinical trial data presented. ## Technological Characteristics Pressure-applying device with multi-axis adjustable stand, force application probe, and controller. Operates via mechanical impulse delivery. Designed to IEC 60601-1 and IEC 60601-1-2 standards. Connectivity/software details not specified beyond integrated control system. ## Predicate Devices - The Atlas Orthogonal Percussion Instrument ([K951217](/device/K951217.md)) ## Reference Devices - US Patent No. 4,461,286 - US Patent No. 4,841,955 - US Patent No. 4,549,535 - US Patent No. 5,618,315 - US Patent No. 6,602,211 ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K060043 D. 1/4 # 510(k) SUMMARY # Khan Kinetic Treatment Device (KKT-M1) Common Name: Manipulator Device Classification: Unclassified Optima Health Solutions International, Inc. Unit 303, 828 West 8th Avenue Vancouver, British Colombia, Canada V5Z 1E2 Contact: Bram Ramjiawan Tel: 204-984-4623 Fax: 204-983-8835 Prepared: November 6, 2005 ### LEGALLY MARKETED PREDICATE DEVICES A. The Khan Kinetic Treatment Device (KKT-M1) is equivalent to a similar pressure applying device - The Atlas Orthogonal Percussion Instrument. ### Information on the Predicate Device | Name: | The Atlas Orthogonal Percussion Instrument | |------------------------------|--------------------------------------------| | Classification Product Code: | LXM | | 510(k) Number: | K951217 | | Marketed by: | Sweat Chiropractic Clinic | | Address: | 3274 Buckeye Rd. N.E, Atlanta, GA 30341 | | FDA Establishment #: | 1039671 | Summary: The device is a pressure applying device that is a comparable to the KKT-M1 device. #### B. DEVICE DESCRIPTION ## Indication for use The KKT device is to be used in the aid of management of chronic pain due to non-congenital defects. The device can be used as part of a series of steps in the total care of the patient. The device is to be used for the treatment of vertebral motor units which appear to be fixated. The procedure can involve xray analysis that quantifies the lateral and rotational misalignments between the vertebrae. The treatment is then administered using the KKT device to deliver precise impulses at a required vector configuration. {1}------------------------------------------------ # The Device The KKT device provides an integrated treatment system unlike manual manipulation of the upper cervical spine, applying significantly smaller forces than those applied manually. While other handheld devices have been used which employ similar treatment methods, the KKT device provides significant advancement and improvement in moments, the ANT repeatability. Image /page/1/Picture/4 description: The image shows a piece of medical equipment. The equipment has a tall, rectangular base with a series of controls on the front. A horizontal arm extends from the top of the base, supporting a large, box-shaped component with a dark rectangular area on its side. A white piece of paper is placed on a surface near the base of the equipment. {2}------------------------------------------------ Image /page/2/Figure/2 description: This image shows a diagram of a Khan Kinetic Treatment Device. The device consists of a display and controller, a force application probe, and a multi-axis adjustable stand. The device is used to apply force, rotation, and vibration to a patient. ## Similarities and Differences to Comparative Device The KKT device is similar and comparable to pressure applying devices (reference CFR 21 Part 890, Sec. 890.5765) as well as percussion devices/percussors (reference CFR 21 Part 882, Sec. 882.1700). A comparable pressure applying device is the Atlas Orthogonal Percussion Instrument which is from Sweat Chiropractic Clinic. The Atlas Orthogonal Percussion Instrument is registered with the FDA under establishment license number 1039671 and is patented under US Patent No. 4,461,286 (issued to Sweat). Other devices patented that are similar or operate using the same principles include: US Patent No. 4,841,955 (issued to Evans), US Patent No. 4,549,535 (issued to Wing), US Patent No. 5,618,315 (issued to Elliott), and US Patent No. 6,602,211 (issued to Tucker). The key difference between the KKT device and applying pressure via manual manipulation or via different impulse methods is that the KKT device provides an integrated treatment system that applies adjustable, modifiable forces in a more effective method and it provides significant advancement and improvement in positioning, accuracy and repeatability. {3}------------------------------------------------ ember 6, 2005 P. 4/4 ### C. TESTING | Requirement | Method of Compliance | Comment | |--------------------------------------|----------------------------------------------------------------------------|-----------------------------------| | Electrical | CSA 601.1 and UL
2601/60601-1, with CB
Report done to IEC
60601.1 | See the KKT Device Technical File | | EMC | IEC 60601.1-2 | See the KKT Device Technical File | | KKT Device
Verification Test Plan | Formal Design
Verification Procedure | See the KKT Device Technical File | ### D. STANDARDS The KKT device was designed according to the medical device standards IEC60601-1, IEC60601-1-2 and the relevant EMC standards: - . EN55022 - . EN61000 These standards, or variations thereof, are relevant to entry into other markets such as China, Canada, Australia and Japan. The KKT device has received Health Canada approval for use, sale and marketing. ### E. CONCLUSIONS This submission for the Khan Kinetic Treatment device seeks to obtain approval for marketing in the US, a product that is intended to be used in chiropractic clinics. The device's intended use is for aid in management of chronic pain. More specifically, conditions of chronic pain is is is from structural anomalies such as misalignments and muscle imbalances. The device is safe and effective and is similar to the FDA approved predicate device (The Atlas Orthogonal Percussion Instrument (K951217)). The current practices of performing manual spinal adjustments for the relief of pain have received negative attention due to the occurrence of injury. Unintended injury in these situations has occurred because of unregulated manual force generated by the individual clinicisn. This device was developed to minimize (relative to the current practice of manual adjustments) potential harm by having a system that generates impulses as opposed to uncontinuits. mechanical force alone to stimulate areas of interest. Numerous built-in mechanisms have been incorporated into the device to ensure safety. {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" are arranged in a circle around the eagle. The eagle is black, and the text is also black. The logo is simple and recognizable. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 2 3 2006 Optima Health Solutions International, Inc. c/o Dr. Bram Ramjiawan Industrial Technology Advisor IRAP West National Research Council Industrial Research Assistance Program 435 Ellice Avenue Winnipeg, Manitoba, Canada R3B 1Y6 Re: K060043 Trade/Device Name: Khan Kinetic Treatment Device (KKT-M1) Regulatory Class: Unclassified Product Code: LXM Dated: November 27, 2005 Received: January 26, 2006 Dear Dr. Ramjiawan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set {5}------------------------------------------------ Page 2 – Dr. Bram Ramjiawan forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Helena Lemes Mark N. Melkerson Director Division of General, Restorative, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {6}------------------------------------------------ # Indications for Use ### 510(k) Number (if known): K060043 Device Name: Khan Kinetic Treatment (KKT) Device ### Indications for Use: The KKT device is to be used in the aid of management of chronic pain due to non-congenital defects. The KN P device is to be asseries of steps in the total care of the patient. The device is to be rine device our of wood as a pebral motor units which appear to be fixated. The procedure can involve xray analysis that quantifies the lateral and rotational misalignments between the vertebrae. The treatment ray analysis that quantinos the factor and readiver precise impulses at a required vector configuration. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Hulut Semen (Division Sign-Off) Division of General, Restorative, and Neurological Devices 510(k) Number_ 06043 Page 1 of ____________________________________________________________________________________________________________________________________________________________________ --- **Source:** [https://fda.innolitics.com/device/K060043](https://fda.innolitics.com/device/K060043) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com